Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function

ConclusionsThe ssGSEA score we constructed can serve as a biomarker for GC patients and provide important guidance for individualized treatment. In addition, theCOX7A1 gene can accurately distinguish the prognosis of GC patients and predict the clinical efficacy of immunotherapy for GC patients.
Source: European Journal of Medical Research - Category: Research Source Type: research